Sort by
Refine Your Search
-
Employer
-
Field
-
) or closely related field. Process simulation : Aspen HYSYS/Plus. Optimization skills: experience with GAMS or pyomo (or similar), including model formulation. Life Cycle Assessment (LCA): experience with, e.g
-
simulation : Aspen HYSYS/Plus. • Optimization skills: experience with GAMS or pyomo (or similar), including model formulation. • Life Cycle Assessment (LCA): experience with, e.g., Brightway2/SimaPro/Activity
-
/PhD) or related field. - Simulation & data: TRNSYS (or similar), time-series processing; Python (pandas/numpy). - Experience with GIS and/or climate/solar datasets (e.g., METEONORM, PVGIS
-
Engineering). - Theoretical foundations of 6G RAN and autonomous systems o Proven knowledge of AI-native RAN systems. Indicative skills/experience: - Deep understanding of 5G/6G RAN architecture (O-RAN, NG-RAN
-
(primary and hPSCs derived). • Protein Purification. • Tau seed characterization and optimization. • Development and implementation of an in vitro reconstituted model. • Analysis of the effect of tau seed
-
doctorate (including additional funding to complete the cycle of the third year). -Flexible work dynamics. -Possibility to extend the duration for the contract. Selection process The selection process will
-
: Synthesis and optimization of PLGA-based nanoparticles and enzymatic nanomotors. Drug loading/release studies in cellular models. Development of patient-derived mucus-secreting tumor-on-a-chip model
-
coatings using techniques like electrodeposition and dip coating. •Develop and characterize porous TiO₂ and metal oxide thin films. •Establish and optimize 3D in vitro skin models for biological testing
-
methods (CASSFCF/NEVPT2). - Stage 2: Support in the analysis of molecular diffusion processes through membranes by means of molecular dynamics studies, oriented to optimize the response as MRI contrast
-
Predoctoral researcher at the Targeted Therapeutics & Nanodevices Research Group (Project BRAINZYME)
, precise transport, controlled release, and therapeutic activity. • Characterize and optimize these biotherapeutics in vitro by assessing their structure, functionality, and stability under storage and